补充系统作为癌症免疫治疗的目标.
Nicolas S Merle1, Lubka T Roumenina1
1Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, Université Paris Cité, Inflammation, Complement and Cancer team, Paris, France.
European journal of immunology
|July 12, 2024
概括
补体系统在癌症中具有双重作用,有时与瘤作斗争,有时促进炎症和生长. 针对补充剂的个性化疗法是必要的,因为它在癌症中具有复杂的,取决于背景的影响.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 瘤微环境涉及恶性细胞,宿主细胞和可溶性介质 (如补充) 之间的复杂相互作用.
- 补体系统在癌症中扮演着双重角色,表现出抗瘤 (opsonophagocytosis,细胞毒性) 和前瘤 (通过C5a/C5aR1轴的炎症) 作用.
- 补充基因共同表达模式因癌症类型而异,影响患者的预后.
研究的目的:
- 审查补充成分在不同癌症类型和患者队列中的多方面的作用.
- 突出补充对癌症影响的上下文依赖性,强调"一个尺寸不适合所有人".
- 总结目前针对癌症补充剂的临床试验,并倡导定制的治疗策略.
主要方法:
- 关于研究补充系统参与癌症的研究文献综述.
- 补充基因共同表达模式的分析及其与预后的相关性.
- 针对补充向癌症疗法的正在进行的临床试验摘要.
主要成果:
- 补充物表现出抗瘤和前瘤功能,受C5a/C5aR1轴和T细胞反应等因素的影响.
- 不同的补充基因表达模式与不同癌症的不同预后有关.
- 患者内异质性和局部产生的/细胞内补充的作用增加了瘤微环境动态的复杂性.
结论:
- 补充剂在癌症中的作用高度依赖于环境,在癌症类型和个体患者之间有很大差异.
- 量身定制的治疗方法对于有效的补充向癌症疗法至关重要.
- 了解补充作用的机制基础将促进个性化癌症治疗,并改善患者的治疗结果.
相关概念视频
Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Vaccines
350
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
350
Cytotoxic T Cells-mediated Immune Response
886
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
886
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


